These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36711204)

  • 21. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
    Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
    Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake Index of
    Kamiya Y; Ota S; Okumiya S; Yamashita K; Takaki A; Ito S
    Asia Ocean J Nucl Med Biol; 2017; 5(1):37-43. PubMed ID: 28840137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
    Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
    Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.
    Oh JK; Choi EK; Song IU; Kim JS; Chung YA
    J Neural Transm (Vienna); 2015 Oct; 122(10):1421-7. PubMed ID: 26003179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
    Stathaki M; Koukouraki S; Simos P; Boura I; Papadaki E; Bourogianni O; Tsaroucha A; Kapsoritakis N; Mitsias P; Spanaki C
    Clin Nucl Med; 2020 Aug; 45(8):588-593. PubMed ID: 32404715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S; Wate R; Kaneko S; Asayama T; Oki M; Tsuge A; Nagashima M; Morita J; Nakamura S; Nakamura M; Nishii M; Fujita K; Saito A; Nakano S; Ito H; Kusaka H
    Acta Neurol Scand; 2013 Sep; 128(3):160-5. PubMed ID: 23410225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
    Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
    Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson's Disease.
    Mizukami H; Shiraishi M; Hino S; Kaburagi M; Matsumoto H; Hagiwara Y; Yamano Y
    Brain Sci; 2024 May; 14(6):. PubMed ID: 38928525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
    Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
    Ryu DW; Kim JS; Lee JE; Oh YS; Yoo SW; Yoo IR; Lee KS
    Clin Nucl Med; 2019 Apr; 44(4):282-288. PubMed ID: 30589669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.
    Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Terada H; Inaoka T
    Parkinsonism Relat Disord; 2014 Mar; 20(3):267-73. PubMed ID: 24332912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease.
    Spiegel J
    Parkinsons Dis; 2010; 2010():295346. PubMed ID: 20975774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autopsy Validation of the Diagnostic Accuracy of
    Matsubara T; Kameyama M; Tanaka N; Sengoku R; Orita M; Furuta K; Iwata A; Arai T; Maruyama H; Saito Y; Murayama S
    Neurology; 2022 Apr; 98(16):e1648-e1659. PubMed ID: 35256483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
    Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.